|
|
|
|
|
|
| PIPELINE REPORT |
|
|
Pharm Exec’s 2020 Pipeline Report
|
Our Annual Pipeline Report examines six key areas of biopharma R&D—a mix of emerging and maturing—where promising research efforts are now beginning to pay dividends, as novel advances in science usher in new treatment approaches and curative therapies.
... /Read more/
|
|
|
| Advertisement |
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
 On Demand
|
| Q & A |
|
|
Olivier Laureau, Servier: Free to Grow, Innovate
|
Unencumbered by shareholder demands, the French independent pharma Servier Group, led by president Olivier Laureau, is uniquely positioned to capitalize on new opportunities for expansion and stay true to its R&D and patient-focused mission.
... /Read more/
|
|
|
| Advertisement |
Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
 On Demand
|
|
|
| Gene Therapy |
|
|
R. Jude Samulski: Gene Therapy’s Guiding Force
|
Chronicling the career “trek” of gene therapy visionary R. Jude Samulski, whose work uncovering the mysteries of adeno-associated virus while navigating the field’s reputational turbulence continues to fuel new hopes for AAV vector technology in transforming therapies for rare disease.
... /Read more/
|
|
|
| The Pharm Exec Podcast: Episode 44 |
|
|
|
|
|
|
On Demand
On Demand